CAR1920 mRNA CAR-T Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR1920 mRNA CAR-T Therapy, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Polymer-lipid Particle-delivered CAR1920 mRNA CAR-T Therapy for Relapsed/Refractory B-cell Lymphoma/Leukemia [Phase 2]